Oral Anticoagulation Therapy: Cases and Clinical CorrelationKathryn Kiser Given the amount and complexity of information surrounding the the target specific oral anticoagulants a lengthy didactic educational format has the potential to be overwhelming to the reader and difficult to translate and apply to direct patient care. The proposed book will educate clinicians utilizing a series of clinical cases to simultaneously develop the readers’ knowledge base, problem-solving skills, and practically apply their new knowledge to a variety of clinical situations. These will be short focused case presentations that provide critical information and pose questions to the reader at key points in the decision making process. The cases will be relevant to what clinicians will encounter not only on a daily basis, but also reflective of scenarios that clinicians will not encounter regularly, but that they will have to act upon (e.g. a bleeding patient, patient scheduled for elective or emergent procedure, patient with changing renal function, patient on drugs that have a plausible yet unstudied drug interaction with a target specific oral anticoagulant etc). Included in the case studies will be evidence-based discussions (with appropriate references) that provide immediate feedback on the different treatment alternatives that were offered. The case studies will be designed to instruct the reader how to select and effectively utilize the most appropriate agent for a given clinical scenario. They will focus on key features of the target specific oral anticoagulants, what they have in common, how they are unique from each other, as well as illustrating the clinical decision process one should take when selecting an agent or managing a patient already receiving one of the target specific oral agents. |
Other editions - View all
Oral Anticoagulation Therapy: Cases and Clinical Correlation Kathryn Kiser No preview available - 2017 |
Common terms and phrases
acute adherence agents agulation American College anti-Xa levels antithrombotic therapy aortic apixaban appropriate aPTT aspirin assess atrial fibrillation bleeding risk cancer chronic kidney disease clopidogrel considered coronary correct answer creatinine dabigatran dabigatran 150 mg dalteparin direct oral anticoagulants DOACs dose adjustments drug interactions drug-drug interactions edoxaban embolism enoxaparin fondaparinux hemorrhage heparin high risk hypertension idarucizumab incorrect INR goal international normalized ratio Kiser lisinopril LMWH major bleeding metabolism mg daily mg twice daily mitral monitoring NSAIDs once daily options oral anticoagulants DOACs Oral Anticoagulation Therapy P-gp inhibitors package insert parenteral anticoagulant patients with atrial Pharmacy PharmD prior procedure prophylaxis Publishing AG 2017 recommended renal function reversal risk factors risk of bleeding rivaroxaban Self-Assessment Questions Springer International Publishing stenosis stent surgery therapeutic Thrombolysis tion treatment USA e-mail venous thromboembolism versus warfarin vitamin vitamin K VTE prophylaxis warfarin warfarin dose warfarin in patients warfarin therapy